Stay updated on Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the previous detailed study content. The page displays an access-denied screen, indicating a site-access issue rather than a data update.SummaryDifference19%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6. This is a minor version bump and does not change study content, eligibility, or results.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page's revision/version label was updated to v3.6.5, signaling a new build of the page.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page revision number was updated from v3.6.3 to v3.6.4, reflecting a minor update to the page.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page version was updated from v3.6.2 to v3.6.3, indicating a minor update to the page. There are no visible changes to the study content or data reflected in the provided information.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page's Revision tag was updated from v3.6.0 to v3.6.2, indicating a new release of the page. This update affects only the version label displayed on the page and does not modify its content.SummaryDifference0.1%

Stay in the know with updates to Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.